References
- Starai TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321(15): 1014–22; 1989: 321(16): 1092–9
- Ferrell LD, Wright TL, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16(4): 865–76
- Demetris AJ, Jaffe R, Sheahan DG, et al. Recurrent hepatitis B in liver allograft recipients: differentiation between viral hepatitis B and rejection. Am J Pathol 1986; 125(l): 161–72
- Sanchez-Urdazpal L, Czaja AJ, van Hoek B, et al. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 1991; 15(2): 215–21
- Kumar S, Stauber RE, Gavaler JS, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990; 11(2): 159–64
- Esquivel CO, Van Thiel DH, Demetris AJ, et al. Transplantation for primary biliary cirrhosis. Gastroenterology 1988; 94(5 Pt 1): 1207–16
- Marsh JW Jr, Iwatsuki S, Makowka L, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988; 207(l): 21–5
- Schafer DF, Shaw BW Jr. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989; 9(3): 189–94
- O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989: 97(2): 439–45
- Emond JC, Aran PP, Whitington PF, et al. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96(6): 1583–8
- Vierling JM. Epidemiology and clinical course of liver diseases: identification of candidates for hepatic transplantation. Hepatology 1984; 4(1 Suppl): 84–94S
- Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116(4): 304–9
- Maddrey WC, Van Thiel DH. Liver transplantation: an overview. Hepatology 1988; 8(4): 948–59
- Wiesner RH, Porayko MK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992; 16(5): 1290–9
- Long RG. Hepatic osteodystrophy: outlook good but some problems unsolved. (Editorial) Gastroenterology 1980; 78(3): 644–7
- Poison RJ, Portmann B, Neuberger J, et al. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis: clinical and histologic follow-up studies. Gastroenterology 1989; 97(3): 715–25
- O'Grady JG, Poison RJ, Rolles K, et al. Liver transplantation for malignant disease: results in 93 consecutive patients. Ann Surg 1988; 207(4): 373–9
- Stone MJ, Klintmalm GB, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104(l): 196–202
- Koneru B, Cassavilla A, Bowman J, et al. Liver transplantation for malignant tumors. Gastroenterol Clin North Am 1988; 17(l): 177–93
- de Groen PC. Cyclosporine and the liver: how one affects the other. Transplant Proc 1990; 22(3): 1197–202
- Wiesner RH, Ludwig J, van Hoek B, et al. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14(4 Pt l): 721–9
- Ascher NL, Freese DK, Paradis K, et al. Rejection of the transplanted liver. In: Maddrey WC, ed. Transplantation of the liver. New York: Elsevier, 1988: 167–89
- The U. S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331 (17): 1110–5
- Rubin RH. Infectious disease problems. In: Maddrey, ed,” pp 279–308
- Yee GC. Pharmacokinetic interactions between cyclosporine and other drugs. Transplant Proc 1990; 22(3): 1203–7
- Mason J. Renal side-effects of cyclosporine. Transplant Proc 1990; 22(3): 1280–3